MCM
DCPH

Moore Capital Management’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Moore Capital Management’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-50,000
Closed -$636K – 564
2023
Q3 		$636K Buy
+50,000
New +$690K 0.01% 327

Other funds holding DCPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Moore Capital Management's DCPH Position: Q4 2023 in Review

Moore Capital Management sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q4 2023, closing a stake of 50,000 shares — an estimated $636K sold.

Moore Capital Management first reported a position in DCPH in Q3 2023 and held it in 1 quarter. The position peaked at $636K in Q3 2023. 164 funds tracked by Wall St. Rank hold DCPH as of Q4 2023.

  • Moore Capital Management reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Moore Capital Management sold 50,000 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q4 2023, an estimated $636K.
  • Moore Capital Management first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q3 2023 and held it in 1 quarter.
  • Moore Capital Management's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $636K in Q3 2023.
  • 164 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q4 2023.

Based on Moore Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.